Oregon Health & Science University
Portland, Oregon, 97239, United States
NCT Number: NCT00614406
The investigators propose to test the hypothesis that the use of a prostaglandin inhibitor will result in premature luteolysis (ovulation failure) in women.
Looking for future studies?
Notify Me18 year–35 year
Female
Interventional
Not applicable
Portland, Oregon, 97239, United States
Currently available methods of emergency contraception (EC) only work during a very narrow time period prior to the hormonal trigger for ovulation or the release of an egg. Women having unprotected sex outside this window receive no benefits from this emergency therapy. Prostaglandins are critical before, during, and after ovulation, thus their inhibition may cause an EC effect that works over a longer time period. We wanted to determine if celecoxib might work as an EC with a wider window of action.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
One 400mg tablet daily.
One tablet daily.
Time frame: 3 months
Menstrual cycle length was measured by the number of days subjects noted menstruating in their diary entry.
Oregon Health and Science University
Other
The Effects of a Prostaglandin Inhibitor on Ovulation and the Menstrual Cycle.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.